Next-Generation Cell and Gene Therapies: Cancer and Beyond
Course Start: October 26, 2026
The purpose of this course is to provide a comprehensive overview of next-generation cell and gene therapies and their potential to transform the treatment of cancer as well as other complex diseases. The participants will engage with the methods of cell and gene engineering through interactive toolbox sessions, facilitated in a flipped classroom format where students take the lead. Participants will gain an in-depth understanding of the principles and methods underlying cellular engineering, gene editing, and immunotherapy, while exploring how these technologies have evolved to address diverse medical challenges.
Course info
- Type: University Course
- Organization: Karolinska Institutet
- Start Date: October 26, 2026
- Language: English
- Place: Campus Flemingsberg
Photo: Karolinska Institutet | Andreas Andersson
The course will examine current developments in the field, including CAR-T cells, tumor-infiltrating lymphocytes, gene-modified hematopoietic stem cells, and emerging in vivo gene editing strategies. Attention will also be given to considerations related to clinical translation, such as treatment resistance, safety, scalability, and regulatory aspects, while maintaining a broader perspective on scientific advances. Finally, the course will discuss future directions in cell and gene therapy, highlighting their role in shaping personalized medicine and expanding therapeutic opportunities across a wide range of difficult-to-treat diseases.
Course code: H7F6092
Course format: University Doctoral Programme Course
Course duration: 1.5 ECTS